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Abst rac t
Background and purpose: A few single nucleotide polymor-
phisms (SNPs) on chromosome 4q25, associated with atrial
fibrillation (AF), are risk factors for ischaemic stroke. We
studied the significance of the SNP rs2200733 on chromo-
some 4q25 in different types of cardioembolic (CE) stroke.
Material and methods: We genotyped 428 controls and 
301 CE stroke patients, among whom 197 (65.4%) present-
ed with high risk sources of embolism (CE stroke related 
to AF) and 104 with medium risk sources (CE stroke unre-
lated to AF). The SNP rs2200733 was analysed using real-
time polymorphism chain reaction.
Results: Both univariate and multivariate regression analyses
showed that the studied variant affected risk of all CE strokes
or CE strokes related to AF in recessive and additive mo dels.
The two types of CE stroke differed significantly in demo-
gra phics and distribution of vascular risk factors.
Conclusions: The SNP rs2200733 on chromosome 4q25 is
a risk factor for CE stroke related to AF only.
Key words: cardioembolic stroke, atrial fibrillation, poly-
morphism.
The rs2200733 variant on chromosome 4q25 is a risk factor for cardioembolic
stroke related to atrial fibrillation in Polish patients
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SHORT REPORT/KRÓTKIE DONIESIENIE
St reszczenie
Wstêp i cel pracy: Kilka polimorfizmów na chromosomie
4q25, zwi¹zanych z migotaniem przedsionków, jest czynni-
kami ryzyka udaru niedokrwiennego mózgu. Przeanalizo-
wano znaczenie polimorfizmu rs2200733 na chromosomie
4q25 w ró¿nych typach udaru sercowozatorowego.
Materia³ i metody: Badany polimorfizm oznaczono u 428
osób tworz¹cych grupê kontroln¹ oraz u 301 chorych na udar
sercowozatorowy, spoœród których 197 (65,4%) mia³o Ÿród³o
zatorowoœci o du¿ym ryzyku (udar sercowozatorowy zwi¹zany
z migotaniem przedsionków), a 104 o poœrednim ryzyku
(udar sercowozatorowy niezwi¹zany z migotaniem przed-
sionków). Do analizy polimorfizmu rs2200733 wykorzysta-
no reakcjê ³añcuchow¹ polimerazy DNA z analiz¹ iloœci pro-
duktu w czasie rzeczywistym.
Wyniki: Zarówno jedno-, jak i wieloczynnikowa analiza regre-
sji logistycznej wykaza³y, ¿e badany wariant wp³ywa³ na ryzy-
ko wyst¹pienia wszystkich udarów sercowozatorowych oraz
tych zwi¹zanych z migotaniem przedsionków w modelach
recesywnym i addytywnym. Dwa typy udaru sercowozatoro-
wego ró¿ni³y siê w zakresie czynników demograficznych oraz
rozk³adu naczyniowych czynników ryzyka.
Correspondence address: Marcin Wnuk, Uniwersytet Jagielloñski, Collegium Medicum, Katedra i Klinika Neurologii, ul. Botaniczna 3, 31-503 Kraków,
e-mail: marcin.a.wnuk@gmail.com
Received: 25.08.2010; accepted: 19.02.2011
*These authors contributed equally to the study
Neurologia i Neurochirurgia Polska 2011; 45, 2 149
Introduction
A recent genome-wide association study (GWAS)
revealed that a haplotype block on chromosome 4q25
predisposed to atrial fibrillation (AF) [1]. In this block,
two variants were in strong linkage disequilibrium 
and defined three haplotypes. One of them, rs2200733,
increased the risk of AF by 1.72, and the second one,
rs10033464, by 1.39. The association of the rs2200733
variant with AF was then confirmed in several replica-
tion populations [2].
The significance of the rs2200733 variant as a risk
factor for stroke was studied in another large GWAS
[3]. The results from this study, combined with the 
data from four replication European populations, show -
ed that the T allele of the rs2200733 variant reached
GWAS significance as a risk factor for all strokes 
without considering aetiology, cardioembolic (CE) or
non-CE strokes [3].
In the previous study performed in co-operation with
investigators from 5 different countries and including
4190 ischaemic stroke patients and 3740 controls, we
replicated the association of the single nucleotide poly-
morphism (SNP) rs2200733 with atrial fibrillation and
ischaemic stroke of cardioembolic aetiology [4]. In the
present case-control study, we evaluated the role of the
rs2200733 variant on chromosome 4q25 in patients with
cardioembolic stroke related or unrelated to AF. So far
such division of cardioembolic stroke patients has never
been performed according to the genetic risk factors.
Material and methods
Consecutive patients with CE stroke, diagnosed ac -
cording to the TOAST criteria [5], admitted to the
Stroke Unit, Department of Neurology, University Ho -
s pital in Cracow, between 2005 and 2010, were includ-
ed in the study.
Information on potential cardiac sources of embolism
was based on previous medical documentation or inves-
tigations performed during the current hospitalization
(ECG – 100%, carotid ultrasound – 71%, echocardio-
graphy – 62%). There were 197 cases with AF (65.4%).
In the remaining 104 cases, CE stroke was diagnosed
because of low ejection fraction due to ischaemic heart
disease (n = 72), myocardial infarction (n = 13), atrial
septal defect (n = 12) or bioprosthetic cardiac valve 
(n = 7) (CE stroke unrelated to AF). 
Controls were collected as described previously [6].
Information on demographics and vascular risk factors
from patients and controls was collected as described
previously [6]. The rs2200733 polymorphism was iden-
tified using real-time polymorphism chain reaction 
RT-PCR [7]. This study was performed according to
the Helsinki Declaration with approval of the local 
Ethical Committee. All individuals gave informed con-
sent. 
Comparisons between the groups were made with
χ2 test or Student’s t-test. The Hardy-Weinberg equi-
librium was tested by the χ2 method. The association of
the rs2200733 genotypes with the risk of CE stroke  
was tested using univariate and multivariate logistic
regression analyses (SPSS 10 for Windows).
Results
The study included 301 CE stroke patients and 
428 controls. There was no deviation from Hardy-Wein-
berg equilibrium regarding the SNP rs2200733 in the
studied groups. 
Patients with CE stroke related to AF as compared
to others were older, more often male and had different
distribution of the vascular risk factors (Table 1).
All CE stroke patients had significantly higher
prevalence of the genotypes with the T allele (CC – 189
[62.8%], CT – 101 [33.6%], TT – 11 [3.7%]) than
controls (CC – 307 [71.7%], CT – 109 [25.5%], 
TT – 12 [2.8%]) (χ2, p < 0.05). The distribution of
the polymorphism was significantly different between
CE strokes with AF (CC – 116 [58.9%], CT – 70
[35.5%], TT – 11 [5.6%]) and without AF (CC – 73
[60.2%], CT – 31 [29.8%], TT – 0) (χ2, p < 0.05).
Both univariate and multivariate regression analy-
ses revealed that the T allele of the studied variant af -
Wnioski: Polimorfizm rs2200733 na chromosomie 4q25 
jest czynnikiem ryzyka jedynie udaru sercowozatorowego
zwi¹zanego z migotaniem przedsionków.
S³owa kluczowe: udar sercowozatorowy, migotanie przed-
sionków, polimorfizm.
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fected the risk of all CE strokes or CE strokes relat-
ed to AF in recessive and additive models of inheri-
tance (Table 2).
Discussion
Based on our data, we suggest that patients with 
the two types of CE stroke, with high or medium risk
sources of cardioembolism, should be considered sepa-
rately because they present with different distribution of
vascular and genetic risk factors. In the present study it
was also revealed that patients with CE stroke related or
unrelated to AF differed in terms of demographic pre-
sentation. To our knowledge, this is the first study show-
ing significant heterogeneity among CE stroke patients
which, according to the TOAST criteria, belong to one
subgroup. Previous studies showed only a difference in
the distribution of vascular risk factors among subtypes of
ischaemic stroke based on the TOAST classification [8,9].
The TOAST criteria are useful in respect of pro-
phylaxis of ischaemic stroke. Cardioembolic stroke can
be diagnosed in a wide range of cardiac disorders: from
Cardioembolic stroke Cardioembolic stroke OR (95% CI)*
related to atrial fibrillation unrelated to atrial fibrillation
(N = 197) (N = 104)
Hypertension 168 (85.3%) 75 (72.1%) 2.24 (1.25-4.01)**
Diabetes mellitus 69 (35%) 20 (19.2%) 2.26 (1.28-4.00)**
Ischaemic heart disease 147 (74.6%) 67 (64.4%) 1.62 (0.97-2.71)
Myocardial infarction 35 (17.8%) 46 (44.2%) 0.28 (0.17-0.49)**
Hypercholesterolaemia 79 (40.1%) 64 (61.5%) 0.41 (0.25-0.67)**
Smoking*** 23 (11.7%) 41 (39.4%) 0.19 (0.11-0.35)**
Table 1. The profile of risk factors in patients with cardioembolic stroke related and unrelated to atrial fibrillation
*OR (95% CI); logistic regression analysis adjusted for age and gender
**p < 0.05
***26 (13.2%) patients with cardioembolic stroke related to atrial fibrillation and 12 (11.5%) unrelated to atrial fibrillation did not give information on their smoking habits
Crude OR* p-value OR adjusted for all p-value OR adjusted for all p-value
studied risk factors** studied risk factors** 
except for AF
All CE strokes
dominant model 1.31 (0.57-3.02) 0.52 0.61 (0.17-2.27) 0.47 1.53 (0.49-4.80) 0.47
recessive model 1.50 (1.10-2.06) 0.01 1.37 (0.83-2.67) 0.22 1.64 (1.06-2.53) 0.025
additive model 1.40 (1.06-1.83) 0.01 1.20 (0.78-1.87) 0.41 1.51 (1.04-2.21) 0.03
CE strokes related to AF
dominant model 2.05 (0.89-4.74) 0.09 N/A – 2.74 (0.78-9.65) 0.11
recessive model 1.77 (1.24-2.52) 0.002 N/A – 2.14 (1.27-3.62) 0.004
additive model 1.64 (1.22-2.21) 0.001 N/A – 1.95 (1.25-3.04) 0.003
CE strokes unrelated to AF
dominant model N/A – N/A – N/A –
recessive model 1.08 (0.67-1.73) 0.76 N/A – 1.24 (0.67-2.31) 0.50
additive model 0.95 (0.62-1.46) 0.82 N/A – 1.07 (0.61-1.89) 0.80
Table 2. Relative risk of cardioembolic (CE) ischaemic stroke in carriers of the SNP rs2200733
*Odds ratios (OR) with 95% confidence intervals
**Age, gender, hypertension, diabetes mellitus, ischaemic heart disease, myocardial infarction, hypercholesterolaemia, smoking and atrial fibrillation (AF) 
N/A – non-applicable (due to the lack of TT genotype in CE strokes unrelated to AF)
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atrial fibrillation, through recent myocardial infarction
and infective endocarditis, to congestive heart failure with
low ejection fraction and cardiomyopathy. All pa tients
with these potential cardioembolic conditions should be
treated with antithrombotic drugs in contrast to patients
with other ischaemic stroke aetiologies in whom
antiplatelet drugs represent the first line of treatment.
However, when investigating the pathophysiology
and genetics of ischaemic stroke, the TOAST system
seems to be outdated. Even in our research the studied
polymorphism was not an independent risk factor for
stroke until all CE stroke patients were divided into two
subgroups, related or unrelated to AF. It is worth con-
sidering these two subtypes of CE stroke separately in
future studies concerning pathophysiology and genetic
risk factors of stroke.
In conclusion, we revealed that the T allele of the
rs2200733 variant was a risk factor for CE stroke speci-
fically related to AF. Although the TOAST diagnostic
system in stroke genetic studies has only modest intra-
rater reliability [10], it is still used in the research con-
cerning genetic risk factors for stroke. Thus, we recom -
mend that patients with CE stroke should be divided
into at least two separate subgroups on the basis of 
the genetic and clinical differences shown in our study.
However, because of the relatively small group size,
future studies are needed to confirm our results.
Conclusions
The SNP rs2200733 on chromosome 4q25 is a risk
factor for CE stroke related to AF only.
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